EFL

Cohort Year: 2023-2024

Tracks: Life Sciences

VISIT WEBSITE

Ambulero

Ambulero is advancing new cell and gene therapy products to treat patients with advanced vascular disease and non-healing wounds, where the standard of care is often amputation.